<?xml version="1.0" encoding="UTF-8"?>
<ref id="B70-vaccines-08-00098">
 <label>70.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Golden</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>Shoemaker</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Lindquist</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Zeng</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Daye</surname>
    <given-names>S.P.</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Coffin</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Olschner</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Flusin</surname>
    <given-names>O.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection</article-title>
  <source>Sci. Adv.</source>
  <year>2019</year>
  <volume>5</volume>
  <fpage>eaaw9535</fpage>
  <pub-id pub-id-type="doi">10.1126/sciadv.aaw9535</pub-id>
  <pub-id pub-id-type="pmid">31309159</pub-id>
 </element-citation>
</ref>
